Showing results (21-30 of 84) with videos related to

Sort By:
Pageof 9
The Journal of Biological Chemistry|July 7, 2012
SnoN suppresses maturation of chondrocytes by mediating signal cross-talk between transforming growth factor-β and bone morphogenetic protein pathwaysIchiro Kawamura, Shingo Maeda, Katsuyuki Imamura, et al.
Oncology Reports|August 9, 2011
Role of GOLPH3 and GOLPH3L in the proliferation of human rhabdomyosarcomaOsamu Kunigou, Hiroko Nagao, Naoya Kawabata, et al.
Oncology Reports|May 7, 2019
Tranilast enhances the effect of anticancer agents in osteosarcomaTakayuki Nakashima, Satoshi Nagano, Takao Setoguchi, et al.
Molecular Carcinogenesis|October 11, 2018
The histone deacetylase inhibitor LBH589 inhibits undifferentiated pleomorphic sarcoma growth via downregulation of FOS-like antigen 1Yoshinobu Saitoh, Costansia Bureta, Hiromi Sasaki, et al.
Journal of Orthopaedic Surgery (Hong Kong)|December 25, 2013
Paget disease of bone in Japanese patients: a report of three casesSatoshi Nagano, Masahiro Yokouchi, Ryusaku Nagayoshi, et al.
Molecular Cancer|January 14, 2010
Smoothened as a new therapeutic target for human osteosarcomaMasataka Hirotsu, Takao Setoguchi, Hiromi Sasaki, et al.
Experimental and Therapeutic Medicine|January 21, 2017
Computer-assisted quantitative evaluation of bisphosphonate treatment for Paget's disease of bone using the bone scan indexSatoshi Nagano, Shunsuke Nakamura, Hirofumi Shimada, et al.
Journal of Orthopaedic Surgery (Hong Kong)|February 9, 2017
Intraosseous epidermoid cyst of the distal phalanx reconstructed with synthetic bone graftHiromi Sasaki, Satoshi Nagano, Hirofumi Shimada, et al.
Molecular Carcinogenesis|September 4, 2019
Neurotensin receptor 1 is a new therapeutic target for human undifferentiated pleomorphic sarcoma growthHiroto Tokumoto, Takao Setoguchi, Yoshinobu Saitoh, et al.
Pageof 9